Shanghai MicroPort MedBot (Group) (HKG:2252) received approval for the full-department application of the Toumai Laparoscopic Surgery Robot for Remote Surgery from China's National Medical Products Administration, a Wednesday Hong Kong bourse filing said.
Following approval, the device has become the world's first laparoscopic surgical robot approved for the full-department application in remote surgery.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.